Potential usage of ING family members in cancer diagnostics and molecular therapy

Mehmet Gunduz, Kadir Demircan, Esra Gunduz, Naoki Katase, Ryo Tamamura, Hitoshi Nagatsuka

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The Inhibitor of Growth (ING) gene family is an emerging putative type II tumor suppressor gene (TSG). Proteins of INGs (ING1-5), critical modulator of the histone code via PHD fingers, are able to suppress cell growth and proliferation, induce apoptosis, and modulate cell cycle progression. ING proteins are involved in transcriptional regulation of genes, such as the p53-inducible gene p21. ING proteins also serve as shuttling proteins between nucleus and cytoplasm, and dysregulation of this nucleocytoplasmic traffic has been shown in some cancer cells. In cancer cells, ING mRNA levels are often lost or suppressed but the genes are rarely mutated. Recently the potential roles of ING proteins as prognostic biomarkers, detection of aggressive behavior of the tumor as well as prediction of chemo-radiotherapy response have also emerged. In this review, we summarize the up-to-date knowledge on functions of the ING proteins, the protein status in human tumors and discuss as a potential target in the molecular diagnostics and therapy of cancer.

Original languageEnglish
Pages (from-to)465-476
Number of pages12
JournalCurrent Drug Targets
Volume10
Issue number5
DOIs
Publication statusPublished - 2009

Fingerprint

Growth Inhibitors
Molecular Pathology
Genes
Neoplasms
Proteins
Tumors
Therapeutics
Chemoradiotherapy
Histone Code
Cells
p53 Genes
Cell proliferation
Cell growth
Biomarkers
Tumor Suppressor Genes
Histones
Modulators
Fingers
Cell Cycle
Cytoplasm

Keywords

  • Biomarker
  • Head and neck cancer
  • ING family
  • ING1
  • Molecular therapy of cancer
  • Nucleocytoplasmic shuttling

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Potential usage of ING family members in cancer diagnostics and molecular therapy. / Gunduz, Mehmet; Demircan, Kadir; Gunduz, Esra; Katase, Naoki; Tamamura, Ryo; Nagatsuka, Hitoshi.

In: Current Drug Targets, Vol. 10, No. 5, 2009, p. 465-476.

Research output: Contribution to journalArticle

Gunduz, Mehmet ; Demircan, Kadir ; Gunduz, Esra ; Katase, Naoki ; Tamamura, Ryo ; Nagatsuka, Hitoshi. / Potential usage of ING family members in cancer diagnostics and molecular therapy. In: Current Drug Targets. 2009 ; Vol. 10, No. 5. pp. 465-476.
@article{5d53a408bf57425e85cb6e9fb9b50ae2,
title = "Potential usage of ING family members in cancer diagnostics and molecular therapy",
abstract = "The Inhibitor of Growth (ING) gene family is an emerging putative type II tumor suppressor gene (TSG). Proteins of INGs (ING1-5), critical modulator of the histone code via PHD fingers, are able to suppress cell growth and proliferation, induce apoptosis, and modulate cell cycle progression. ING proteins are involved in transcriptional regulation of genes, such as the p53-inducible gene p21. ING proteins also serve as shuttling proteins between nucleus and cytoplasm, and dysregulation of this nucleocytoplasmic traffic has been shown in some cancer cells. In cancer cells, ING mRNA levels are often lost or suppressed but the genes are rarely mutated. Recently the potential roles of ING proteins as prognostic biomarkers, detection of aggressive behavior of the tumor as well as prediction of chemo-radiotherapy response have also emerged. In this review, we summarize the up-to-date knowledge on functions of the ING proteins, the protein status in human tumors and discuss as a potential target in the molecular diagnostics and therapy of cancer.",
keywords = "Biomarker, Head and neck cancer, ING family, ING1, Molecular therapy of cancer, Nucleocytoplasmic shuttling",
author = "Mehmet Gunduz and Kadir Demircan and Esra Gunduz and Naoki Katase and Ryo Tamamura and Hitoshi Nagatsuka",
year = "2009",
doi = "10.2174/138945009788185086",
language = "English",
volume = "10",
pages = "465--476",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Potential usage of ING family members in cancer diagnostics and molecular therapy

AU - Gunduz, Mehmet

AU - Demircan, Kadir

AU - Gunduz, Esra

AU - Katase, Naoki

AU - Tamamura, Ryo

AU - Nagatsuka, Hitoshi

PY - 2009

Y1 - 2009

N2 - The Inhibitor of Growth (ING) gene family is an emerging putative type II tumor suppressor gene (TSG). Proteins of INGs (ING1-5), critical modulator of the histone code via PHD fingers, are able to suppress cell growth and proliferation, induce apoptosis, and modulate cell cycle progression. ING proteins are involved in transcriptional regulation of genes, such as the p53-inducible gene p21. ING proteins also serve as shuttling proteins between nucleus and cytoplasm, and dysregulation of this nucleocytoplasmic traffic has been shown in some cancer cells. In cancer cells, ING mRNA levels are often lost or suppressed but the genes are rarely mutated. Recently the potential roles of ING proteins as prognostic biomarkers, detection of aggressive behavior of the tumor as well as prediction of chemo-radiotherapy response have also emerged. In this review, we summarize the up-to-date knowledge on functions of the ING proteins, the protein status in human tumors and discuss as a potential target in the molecular diagnostics and therapy of cancer.

AB - The Inhibitor of Growth (ING) gene family is an emerging putative type II tumor suppressor gene (TSG). Proteins of INGs (ING1-5), critical modulator of the histone code via PHD fingers, are able to suppress cell growth and proliferation, induce apoptosis, and modulate cell cycle progression. ING proteins are involved in transcriptional regulation of genes, such as the p53-inducible gene p21. ING proteins also serve as shuttling proteins between nucleus and cytoplasm, and dysregulation of this nucleocytoplasmic traffic has been shown in some cancer cells. In cancer cells, ING mRNA levels are often lost or suppressed but the genes are rarely mutated. Recently the potential roles of ING proteins as prognostic biomarkers, detection of aggressive behavior of the tumor as well as prediction of chemo-radiotherapy response have also emerged. In this review, we summarize the up-to-date knowledge on functions of the ING proteins, the protein status in human tumors and discuss as a potential target in the molecular diagnostics and therapy of cancer.

KW - Biomarker

KW - Head and neck cancer

KW - ING family

KW - ING1

KW - Molecular therapy of cancer

KW - Nucleocytoplasmic shuttling

UR - http://www.scopus.com/inward/record.url?scp=67650595192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650595192&partnerID=8YFLogxK

U2 - 10.2174/138945009788185086

DO - 10.2174/138945009788185086

M3 - Article

C2 - 19442118

AN - SCOPUS:67650595192

VL - 10

SP - 465

EP - 476

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 5

ER -